Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
University of Schleswig-Holstein University Hospital, Frankfurt |
---|---|
Information provided by: | University of Schleswig-Holstein |
ClinicalTrials.gov Identifier: | NCT00882622 |
The purpose of this study is to evaluate the effects of Remote Ischemic Preconditioning on cardiac function in patients undergoing cardiac surgery compared to control intervention.
Condition | Intervention | Phase |
---|---|---|
Atrial Fibrillation Ventricular Arrythmias Myocardial Injury Cardiac Function |
Procedure: Remote Ischemic Preconditioning Procedure: Control/sham procedure |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator, Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Effect of Remote Ischemic Preconditioning on Cardiac Function After Cardiac Surgery |
Estimated Enrollment: | 100 |
Study Start Date: | October 2008 |
Estimated Study Completion Date: | December 2010 |
Estimated Primary Completion Date: | October 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
RIPC: Active Comparator |
Procedure: Remote Ischemic Preconditioning
RIPC will be induced during anesthesia by four 5-min cycles of upper limb ischemia and 5-min reperfusion using a blood-pressure cuff inflated to a pressure 15 mm Hg greater than the systolic arterial pressure measured via the arterial line.
|
CONTROL: Sham Comparator |
Procedure: Control/sham procedure
Sham placement of the blood pressure cuff around the upper limb without inflation.
|
In detail, we will focus on new onset of atrial fibrillation, ventricular arrhythmias, myocardial injury, and cardiac function. Furthermore, we aim to investigate underlying pathways of RIPC in modifying the perioperative stress response.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Patrick Meybohm, MD | +494315972965 | meybohm@anaesthesie.uni-kiel.de |
Germany | |
University Hospital Schleswig-Holstein | Recruiting |
Kiel, Germany, 24105 | |
Contact: Patrick Meybohm, MD meybohm@anaesthesie.uni-kiel.de | |
Principal Investigator: Patrick Meybohm, MD | |
Principal Investigator: Berthold Bein, MD, DEEA | |
Principal Investigator: Martin Albrecht, PhD | |
Principal Investigator: Jochen Cremer, MD | |
University Hospital | Not yet recruiting |
Frankfurt am Main, Germany | |
Contact: Kai Zacharowski, PhD | |
Principal Investigator: Kai Zacharowski, PhD |
Responsible Party: | Department of Anaesthesiology and Intensive Care Medicine ( University Hospital Schleswig-Holstein ) |
Study ID Numbers: | A165/08_2 |
Study First Received: | April 14, 2009 |
Last Updated: | April 15, 2009 |
ClinicalTrials.gov Identifier: | NCT00882622 History of Changes |
Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
Ischemic Preconditioning Cardiac Surgery |
Heart Diseases Anesthetics Ischemia Atrial Fibrillation Arrhythmias, Cardiac |
Pathologic Processes Heart Diseases Cardiovascular Diseases Atrial Fibrillation Arrhythmias, Cardiac |